BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 28867616)

  • 21. Cryo-EM of mammalian PA28αβ-iCP immunoproteasome reveals a distinct mechanism of proteasome activation by PA28αβ.
    Chen J; Wang Y; Xu C; Chen K; Zhao Q; Wang S; Yin Y; Peng C; Ding Z; Cong Y
    Nat Commun; 2021 Feb; 12(1):739. PubMed ID: 33531497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasome Biology: Chemistry and Bioengineering Insights.
    Račková L; Csekes E
    Polymers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks.
    Lesne J; Locard-Paulet M; Parra J; Zivković D; Menneteau T; Bousquet MP; Burlet-Schiltz O; Marcoux J
    Nat Commun; 2020 Dec; 11(1):6140. PubMed ID: 33262340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trash Talk: Mammalian Proteasome Regulation at the Transcriptional Level.
    Kamber Kaya HE; Radhakrishnan SK
    Trends Genet; 2021 Feb; 37(2):160-173. PubMed ID: 32988635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryo-EM structures of the human PA200 and PA200-20S complex reveal regulation of proteasome gate opening and two PA200 apertures.
    Guan H; Wang Y; Yu T; Huang Y; Li M; Saeed AFUH; Perčulija V; Li D; Xiao J; Wang D; Zhu P; Ouyang S
    PLoS Biol; 2020 Mar; 18(3):e3000654. PubMed ID: 32134919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes.
    Toste Rêgo A; da Fonseca PCA
    Mol Cell; 2019 Oct; 76(1):138-147.e5. PubMed ID: 31473102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer.
    Morozov AV; Karpov VL
    Front Oncol; 2019; 9():761. PubMed ID: 31456945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Proteasome Activity by (Post-)transcriptional Mechanisms.
    Kors S; Geijtenbeek K; Reits E; Schipper-Krom S
    Front Mol Biosci; 2019; 6():48. PubMed ID: 31380390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond.
    Albornoz N; Bustamante H; Soza A; Burgos P
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological consequences of structural and functional proteasome diversity.
    Morozov AV; Karpov VL
    Heliyon; 2018 Oct; 4(10):e00894. PubMed ID: 30417153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.
    Jonik-Nowak B; Menneteau T; Fesquet D; Baldin V; Bonne-Andrea C; Méchali F; Fabre B; Boisguerin P; de Rossi S; Henriquet C; Pugnière M; Ducoux-Petit M; Burlet-Schiltz O; Lamond AI; Fort P; Boulon S; Bousquet MP; Coux O
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6477-E6486. PubMed ID: 29934401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased proteasomal activity supports photoreceptor survival in inherited retinal degeneration.
    Lobanova ES; Finkelstein S; Li J; Travis AM; Hao Y; Klingeborn M; Skiba NP; Deshaies RJ; Arshavsky VY
    Nat Commun; 2018 Apr; 9(1):1738. PubMed ID: 29712894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasome substrate capture and gate opening by the accessory factor PafE from
    Hu K; Jastrab JB; Zhang S; Kovach A; Zhao G; Darwin KH; Li H
    J Biol Chem; 2018 Mar; 293(13):4713-4723. PubMed ID: 29414791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Mammalian Proteasome Activator PA28 Forms an Asymmetric α
    Huber EM; Groll M
    Structure; 2017 Oct; 25(10):1473-1480.e3. PubMed ID: 28867616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition.
    Schwarz K; Eggers M; Soza A; Koszinowski UH; Kloetzel PM; Groettrup M
    Eur J Immunol; 2000 Dec; 30(12):3672-9. PubMed ID: 11169410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PA28αβ overexpression enhances learning and memory of female mice without inducing 20S proteasome activity.
    Adelöf J; Andersson M; Porritt M; Petersen A; Zetterberg M; Wiseman J; Hernebring M
    BMC Neurosci; 2018 Nov; 19(1):70. PubMed ID: 30400847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PA28γ: New Insights on an Ancient Proteasome Activator.
    Cascio P
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atomic resolution Cryo-EM structure of human proteasome activator PA28γ.
    Chen DD; Hao J; Shen CH; Deng XM; Yun CH
    Int J Biol Macromol; 2022 Oct; 219():500-507. PubMed ID: 35932807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and functional properties of proteasome activator PA28.
    Kuehn L; Dahlmann B
    Mol Biol Rep; 1997 Mar; 24(1-2):89-93. PubMed ID: 9228287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.